News A maternal RSV vaccine to protect infants is one step closer to FDA approval May 18, 2023Adrianna Rodriguez, USA TODAYComments Off on A maternal RSV vaccine to protect infants is one step closer to FDA approval The candidate vaccine created by Pfizer would be approved for pregnant people to help prevent severe disease in infants from birth through 6 months.